August 26, 2010<\/p>

<\/p>Fresenius Medical Care acquires peritoneal dialysis business from Gambro<\/i><\/b><\/a>

<\/p>Fresenius Medical Care AG & Co. announced that it has signed an agreement to acquire Gambro’s worldwide peritoneal dialysis (PD) business, taking advantage of this opportunity to expand its activities in the homecare market, especially in Europe and Asia-Pacific. +<\/a><\/span><\/div>

<\/p>

<\/a>
August 3, 2010<\/p>
<\/p>Fresenius Medical Care Reports Strong Second Quarter and Half Year Results and Confirms Outlook for 2010<\/i><\/b><\/a>
<\/p>Fresenius Medical Care AG & Co. today announced its results for the second quarter and first half of 2010.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
July 23, 2010<\/p>
<\/p>Fresenius Medical Care enters into long-term distribution agreement in Japan and expands dialysis products business in Korea<\/i><\/b>
<\/p>Fresenius Medical Care AG & Co, has entered into a long-term, 10-year exclusive distribution agreement with Japanese-based Nikkiso Co. Ltd. for hemodialysis and peritoneal dialysis products in Japan.<\/div>
<\/p>
<\/p>
<\/p>
<\/a>
June 30, 2010<\/p>
<\/p>Fresenius Medical Care expands dialysis services business in Russia<\/i><\/b><\/a>
<\/p>The company announced today that it has signed an agreement to acquire KNC (KRAEVOY NEFROLOGICHESKIY CENTR), a private operator of dialysis clinics in Russia’s Krasnodar region.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
May 25, 2010<\/p>
<\/p>Fresenius Medical Care reaches agreement with Bumrungrad International to acquire Asia Renal Care<\/i><\/b><\/a>
<\/p>Fresenius Medical Care AG & Co. KGaA ("the company"), the world’s largest provider of dialysis products and services, today announced its signing of a sales and purchase agreement with Bumrungrad International Ltd. to acquire Asia Renal Care Ltd.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
May 11, 2010<\/p>
<\/p>Fresenius Medical Care Confirms Positive Outlook for 2010 - Shareholders Approve 13th Consecutive Annual Dividend Increase<\/i><\/b><\/a>
<\/p>Fresenius Medical Care’s Chief Executive Officer, Dr. Ben Lipps, continues to see attractive growth opportunities, confirming the company’s positive outlook for the 2010 financial year.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
May 4, 2010<\/p>
<\/p>Fresenius Medical Care Reports Strong Start for 2010 and Confirms Outlook for Full Year<\/i><\/b><\/a>
<\/p>Fresenius Medical Care AG & Co. today announced its results for the first quarter of 2010.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
March 26, 2010<\/p>
<\/p>Fresenius Medical Care Responds to Chilean Earthquake Emergency<\/i><\/b><\/a>
<\/p>Fresenius Medical Care Chile is working to maintain operation of its clinic network and continue ensuring lifesaving dialysis treatment for patients in the country’s recently affected earthquake region.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
February, 24th, 2010<\/p>
<\/p>Fresenius Medical Care Reports Excellent 4th-Quarter and Full-Year 2009 Results; Provides strong outlook for 2010<\/i><\/b><\/a>
<\/p>The company reached its financial targets for 2009, set new records and proposes its 13th consecutive annual dividend increase.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
11 January, 2010<\/p>
<\/p>Fresenius Medical Care Announces the Offering of €250 million of Senior Notes for Refinancing Purposes<\/i><\/b><\/a>
<\/p>Fresenius Medical Care AG & Co. KGaA announced that it intends to sell €250 million of senior unsecured notes due 2016 (the “Senior Notes”) issued by FMC Finance VI S.A., a wholly owned subsidiary of the Company.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
January 14, 2010<\/p>
<\/p>Fresenius Medical Care Successfully Places Senior Notes in the Amount of 250 million euros<\/i><\/b><\/a>
<\/p>Fresenius Medical Care AG & Co. KGaA announced the pricing of Senior Notes due 2016 in the principal amount of 250 million euros issued by FMC Finance VI S.A., a wholly owned subsidiary of the Company (the "Senior Notes").+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
December 9, 2009<\/p>
<\/p>Fresenius Medical Care announces Management Board Changes<\/i><\/b><\/a>
<\/p>Fresenius Medical Care announced a transition to a new management board structure, drawing entirely on internal management strength.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
November 3, 2009<\/p>
<\/p>Fresenius Medical Care Reports Strong Third Quarter and Nine Months Results; Improved Guidance for 2009<\/i><\/b><\/a>
<\/p>Fresenius Medical Care AG announced its results for the third quarter and first nine months of 2009.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
October 13, 2009<\/p>
<\/p>Fresenius Medical Care introduces programme for improved PD therapy<\/i><\/b><\/a>
<\/p>Fresenius Medical Care has launched a new therapy programme for peritoneal dialysis (PD). \'P3\', the first comprehensive PD care concept of its kind, was introduced at the 9th European Peritoneal Dialysis Meeting "EuroPD" in Strasbourg, France this week.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
August 4, 2009<\/p>
<\/p>Fresenius Medical Care Reports Strong Second Quarter and Half Year Results and Confirms Outlook for 2009<\/i><\/b><\/a>
<\/p>Fresenius Medical Care AG, the world’s largest provider of dialysis products and services, announced its results for the second quarter and first half of 2009.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
May 7, 2009<\/p>
<\/p>Fresenius Medical Care Confirms Positive Outlook for 2009 - Shareholders Approve Twelfth Consecutive Annual Dividend Increase<\/i><\/b><\/a>
<\/p>Fresenius Medical Care’s Chief Executive Officer Dr. Ben Lipps continues to see attractive growth opportunities, confirming the company’s positive outlook for the financial year 2009.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
May 6, 2009<\/p>
<\/p>Fresenius Medical Care announces completion of government investigation<\/i><\/b><\/a>
<\/p>Fresenius Medical Care today announced, that the United States Attorney\'s Office for the Eastern District of New York (Brooklyn) has completed its investigation of Fresenius Medical Care\'s North American subsidiaries.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
April 30, 2009<\/p>
<\/p>Fresenius Medical Care Reports Strong Start for 2009<\/i><\/b><\/a>
<\/p>Fresenius Medical Care, the world’s largest provider of dialysis products and services, today announced its results for the first quarter of 2009.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
April 23, 2009<\/p>
<\/p>Fresenius Biotech receives approval for Removab® by European Commission - First Drug worldwide for Treatment of Malignant Ascites<\/i><\/b><\/a>
<\/p>The European Commission has approved Removab (catumaxomab) for the treatment of malignant ascites with immediate effect.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
March 5, 2009<\/p>
<\/p>Fresenius SE joins the DAX 30<\/i><\/b><\/a>
<\/p>Deutsche Börse announced yesterday evening that Fresenius SE will be included in the DAX 30 index on March 23. +<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
February 19, 2009<\/p>
<\/p>Fresenius Medical Care Reports Strong Fourth Quarter and Full Year 2008 Results; Projects continued growth in 2009<\/i><\/b><\/a>
<\/p>The Company reached all its financial targets, achieved record earnings and proposes its 12th consecutive annual dividend increase.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
December 11, 2008<\/p>
<\/p>Fresenius Medical Care’s Peritoneal Dialysis Products Certified by Nordic Ecolabel - First Health Care Company with Ecolabelled Products<\/i><\/b><\/a>
<\/p>Numerous peritoneal dialysis (PD) products of Fresenius Medical Care are now certified by Nordic Ecolabel, making it the first health care company in the world to receive this designation for its medical products.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
4 November, 2008<\/p>
<\/p>Fresenius Medical Care reports strong third quarter and nine months results; Confirms Outlook for 2008<\/i><\/b><\/a>
<\/p>Fresenius Medical Care, the world’s largest provider of Dialysis Products and Services, today announced its results for the third quarter and first nine months of 2008.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
16 September, 2008<\/p>
<\/p>Fresenius Medical Care Announces Closing of the U.S. License Agreement for Intravenous Iron Products<\/i><\/b><\/a>
<\/p>Fresenius Medical Care today announced the closing of an exclusive license agreement with Luitpold Pharmaceuticals, Inc., and its subsidiary American Regent, Inc. for the manufacture and distribution of intravenous (I.V.) iron products in the USA.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
30 July, 2008<\/p>
<\/p>Fresenius Medical Care Confirms Outlook for 2008; Reports Strong Second Quarter and Half Year Results<\/i><\/b><\/a>
<\/p>Fresenius Medical Care today announced its results for the second quarter and first half of 2008.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
July,17, 2008<\/p>
<\/p>Fresenius Medical Care Reports Preliminary Second Quarter and First Six Months 2008 Results<\/i><\/b><\/a>
<\/p>Fresenius Medical Care today announced preliminary results for the second quarter and the first six months of 2008.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
9 July 2008<\/p>
<\/p>Fresenius Medical Care Signs Agreements for Intravenous Iron Products<\/i><\/b><\/a>
<\/p>Fresenius Medical Care today announced that it signed exclusive license agreements for the intravenous (IV) Iron products Venofer® (iron sucrose) and Ferinject® (ferric carboxymaltose) to treat iron deficiency anemia experienced by dialysis patients.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
20 May 2008<\/p>
<\/p>Fresenius Medical Care Reports Strong Start for 2008 - Shareholders Approve Eleventh Consecutive Annual Dividend Increase<\/i><\/b><\/a>
<\/p>Fresenius Medical Care’s Chief Executive Officer Ben Lipps today confirmed the outlook for the remainder of 2008.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
April 30, 2008<\/p>
<\/p>Fresenius Medical Care Reports Strong Start for 2008 and Confirms Outlook for Full Year<\/i><\/b><\/a>
<\/p>Fresenius Medical Care announced its results for the first quarter of 2008 +<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
April 7, 2008<\/p>
<\/p>Fresenius Medical Care Announces Status in Patient Case<\/i><\/b><\/a>
<\/p>Fresenius Medical Care announced that the United States District Court issued orders in the long standing patent case initiated by the Company to establish the invalidity of certain patents claims. +<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
April 2, 2008<\/p>
<\/p>Fresenius Medical Care Announces upgraded Rating of Unsecured Debt Issues by Standard & Poor’s<\/i><\/b><\/a>
<\/p>Fresenius Medical Care AG today reports that Standard & Poor’s has assigned upgraded debt and recovery ratings to the Company’s unsecured debt issues.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
March 6, 2008<\/p>
<\/p>Fresenius Medical Care Expands Dialyzer Production Capacity at St. Wendel, Germany<\/i><\/b><\/a>
<\/p>The Company will invest a total of approximately 39 million euros over the next 12 months.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
February 20, 2008<\/p>
<\/p>Fresenius Medical Care Reports Excellent Fourth Quarter and Full Year 2007 Results and Provides Strong Outlook for 2008<\/i><\/b><\/a>
<\/p>The Company clearly exceeded its financial targets, achieved record earnings and proposes its 11th consecutive annual dividend increase. +<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
January 29, 2008<\/p>
<\/p>Portugal to Introduce a Bundled Rate for Hemodialysis Treatment<\/i><\/b><\/a>
<\/p>Fresenius Medical Care announced that the Portuguese Ministry of Health and Anadial, the national association of privately run dialysis centers, agreed on a new reimbursement model for ambulatory care to hemodialysis patients.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
January 25, 2008<\/p>
<\/p>Fresenius Medical Care Extends Senior Note Exchange Offer<\/i><\/b><\/a>
<\/p>Fresenius Medical Care today announced that its wholly-owned subsidiary, FMC Finance III S.A. had extended the expiration date of its Exchange Offer to the holders of its 6-7\/8% Senior Notes due 2017.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
January 11, 2008<\/p>
<\/p>Fresenius Medical Care Selected to Provide Dialysis Care to More than 400 Patients in the U.K<\/i><\/b><\/a>
<\/p>Fresenius Medical Care today announced that it has been selected by the National Health System (NHS) in the United Kingdom to manage dialysis care for 12 renal units across the North of England +<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
November 29, 2007<\/p>
<\/p>Fresenius Medical Care Acquires Renal Solutions, Inc.<\/i><\/b><\/a>
<\/p>Fresenius Medical Care acquires technology to advance home hemodialysis and create a platform for development of a wearable kidney +<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
7 November, 2007<\/p>
<\/p>Fresenius Medical Care Announces Continued Positive Data from CARE-2 Database<\/i><\/b><\/a>
<\/p>During the American Society of Nephrology’s Renal Week 2007 additional findings from the Calcium Acetate Renagel Evaluation (CARE 2) data set were presented by Dr. Wajeh Qunibi of the University of Texas Health Science Center, San Antonio.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
October 30, 2007<\/p>
<\/p>Fresenius Medical Care Reports Strong Third Quarter and Nine Months 2007 Results; Outlook Now Confirmed at Upper End<\/i><\/b><\/a>
<\/p>Fresenius Medical Care AG & Co. KGaA, the world’s largest provider of Dialysis Products and Services, today announced its results for the third quarter and nine months of 2007.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
August 2, 2007<\/p>
<\/p>Fresenius Medical Care reports strong second quarter and six months 2007 results and raises outlook for full year<\/i><\/b><\/a>
<\/p>Fresenius Medical Care AG & Co. KGaA, the world’s largest provider of Dialysis Products and Services, today announced its results for the second quarter and first half 2007.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
June 25, 2007<\/p>
<\/p>Confirmed by new study: high-flux dialysers improve survival of dialysis patients<\/i><\/b><\/a>
<\/p>Most dialysis patients have a significantly better chance of survival if they are treated with high-flux dialyzers rather than low-flux dialyzers.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
May 2, 2007<\/p>
<\/p>Fresenius Medical Care Reports Outstanding Start for 2007 and Confirms Outlook for Full Year<\/i><\/b><\/a>
<\/p>Fresenius Medical Care AG & Co. KGaA, the world’s largest provider of Dialysis Products and Services, today announced its results for the first quarter of 2007.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
February 22, 2007<\/p>
<\/p>Fresenius Medical Care Reports Excellent Fourth Quarter and Full Year 2006 Results and Provides Strong Outlook for 2007<\/i><\/b><\/a>
<\/p>Fresenius Medical Care AG & Co. KGaA, the world’s largest provider of Dialysis Products and Services, today announced its results for the fourth quarter and full year of 2006.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
January 16, 2007<\/p>
<\/p>Fresenius Medical Care expands dialyser production capacity at St. Wendel (Germany)<\/i><\/b><\/a>
<\/p>Fresenius Medical Care is expanding the dialyzer production capacity at the St. Wendel (Germany) production facility by 40%. A total of €36 million will be invested including associated investment in additional production capacity for proprietary Helixone fibers. The new production line for FX-Class dialyzers is expected to start operating in spring 2008 and will increase the annual capacity for single-use dialyzers from 25 million to 35 million. +<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
January 9, 2007<\/p>
<\/p>Fresenius Medical Care Becomes the Leading Dialysis Provider in Asia<\/i><\/b><\/a>
<\/p>Fresenius Medical Care AG & Co. KGaA continues to expand in Asia. The Company today announced the acquisition of a 51% equity interest in Jiate Excelsior Co. Ltd. in Taiwan.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
December 22, 2006<\/p>
<\/p>Fresenius Medical Care donates 150,000 euros to aid dialysis patients<\/i><\/b><\/a>
<\/p>As part of its 10-year anniversary, Fresenius Medical Care, the worldwide dialysis market leader, will donate 150,000 euros to charitable organizations that aid dialysis patients. The German National Kidney Association (Bundesverband Niere e.V.) will receive 50,000 euros while similar organizations in North America and the Asia-Pacific region will obtain the remaining 100,000 euros. +<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
November 29, 2006<\/p>
<\/p>Fresenius Medical Care Turns Ten Years Donating Funds to the National German Kidney Patient Association<\/i><\/b><\/a>
<\/p>A ten year anniversary is generally a good reason for big celebrations and festivities. But after completing its first decade this fall, the worldwide dialysis market leader Fresenius Medical Care will instead donate 50,000Eur to the Bundesverband Niere e.V, the national German kidney patient association, and focus on what it does best - the care of patients with chronic kidney failure and the development of innovative dialysis products.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
November 21, 2006<\/p>
<\/p>Fresenius Medical Care Announces Positive Results from PhosLo CARE-2 Study<\/i><\/b><\/a>
<\/p>Fresenius Medical Care AG & Co. KGaA today announced positive results from the PhosLo (calcium acetate) CARE-2 (Calcium Acetate Renagel Evaluation) study.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
November 15, 2006<\/p>
<\/p>Fresenius Medical Care Completes the Acquisition of the Phosphate Binder Business From Nabi Biopharmaceuticals<\/i><\/b><\/a>
<\/p>Fresenius Medical Care AG & Co. KGaA today announced that it has completed the acquisition of the worldwide phosphate binder business (PhosLo) from Nabi Biopharmaceuticals Inc.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
October 19, 2006<\/p>
<\/p>Fresenius Medical Care Announces New Sourcing and Suplly Agreement with Amgen<\/i><\/b><\/a>
<\/p>Fresenius Medical Care AG & Co. KGaA (or "Company") today announced that its subsidiary, Fresenius Medical Care Holdings Inc. (FMC-NA) has entered into a new sourcing and supply agreement with Amgen USA, Inc. (Amgen) under which Amgen will supply FMC-NA’s commercial requirements in the United States and Puerto Rico for erythropoiesis stimulating proteins for dialysis patients, inclusive of EPOGEN (Epoetin alfa) and Aranesp (Darbepoetin alfa).+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
October 12, 2006<\/p>
<\/p>Fresenius Medical Care to Acquire Phosphate Binder Business form Nabi Biopharmaceuticals<\/i><\/b><\/a>
<\/p>Fresenius Medical Care AG & Co. KGaA today announced that it has signed a definitive agreement to acquire the worldwide phosphate binder business (PhosLo) from Nabi Biopharmaceuticals Inc. (Nabi).+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
July 20, 2006<\/p>
<\/p>Fresenius Medical Care Receives Regulatory Approval for New Phosphate Binding Agent in Germany<\/i><\/b><\/a>
<\/p>Fresenius Medical Care ("the Company"), the world’s largest provider of Dialysis Products and Services, has received regulatory approval from Germany’s Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte) for a new phosphate binding agent.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
June 26, 2006<\/p>
<\/p>New 5008 Therapy System Wins Design Award<\/i><\/b><\/a>
<\/p>Fresenius Medical Care has been recognized for its new 5008 therapy system with the "red dot award: product design". This therapy system is used for treating for patients with chronic kidney failure. Since 1955, the Design Zentrum Nordrhein Westfalen has been marking outstanding international product design with the award. This year, more than 2,000 products from companies in 41 countries took part in the competition.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
June 2, 2006<\/p>
<\/p>Renal Care Group Subpoenaed Regarding Stock Option Program<\/i><\/b><\/a>
<\/p>Fresenius Medical Care AG & Co. KGaA announced today that its wholly-owned subsidiary, Renal Care Group, Inc., has received a subpoena from the United States Attorney’s Office for the Southern District of New York +<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
May 11, 2006<\/p>
<\/p>Study Shows: Hemodiafiltration Reduces Mortality for Patients with Chronic Kidney Disease by 35 Percent<\/i><\/b><\/a>
<\/p>The mortality rate among patients with kidney disease is significantly lower with hemodiafiltration than with conventional hemodialysis. This is the result of a new study conducted by specialists at the University Hospital in Lapeyronie in Montpellier and led by French nephrology professor Bernard Canaud. The study showed that kidney patients treated with high-efficiency hemodiafiltration (HDF) therapy had a 35 percent better chance of survival than those that received traditional hemodialysis. The three-year Dialysis Outcomes and Practice Patterns Study (DOPPS) from five European countries involved 2,165 patients who received treatment an average of three times per week.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
May 09, 2006<\/p>
<\/p>Shareholders approve Ninth Consecutive Annual Dividend Increase and Elects Supervisory Board<\/i><\/b><\/a>
<\/p>Shareholders of Fresenius Medical Care today approved the ninth consecutive dividend increase at the Annual General Meeting in Frankfurt, Germany. Ordinary shareholders will receive 1.23Eur per share (2004: 1.12Eur) and preference shareholders will receive 1.29Eur (2004: 1.18Eur). Shareholders discharged Management and Supervisory Board with a large majority of more than 90%.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
May 3, 2006<\/p>
<\/p>Fresenius Medical Care Reports First Quarter 2006 Results; Excellent Start into the Year 2006<\/i><\/b><\/a>
<\/p>Fresenius Medical Care AG & Co. KGaA ("the Company") (Frankfurt Stock Exchange: FME, FME3) (NYSE: FMS, FMS-p), the world’s largest provider of Dialysis Products and Services, today announced the results for the first quarter 2006.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
April 27, 2006<\/p>
<\/p>Fresenius Medical Care adopts Section 404 Sarbanes-Oxley Rules Early<\/i><\/b><\/a>
<\/p>Fresenius Medical Care AG & Co. KGaA (Frankfurt Stock Exchange: FME, FME3) (NYSE: FMS, FMS-p), the world’s largest provider of dialysis products and services, is one of the few German companies to voluntarily adopt new U.S. regulations early and assessed the Company’s internal control over financial reporting as effective.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
April 07, 2006<\/p>
<\/p>Fresenius Medical Care Completes Divestiture of Facilities in Connection with Renal Care Group Acquisition<\/i><\/b><\/a>
<\/p>Fresenius Medical Care AG & Co. KGaA (Frankfurt Stock Exchange: FME, FME3) (NYSE: FMS, FMS-p), the world’s largest provider of dialysis products and services, today announced that its subsidiaries, Fresenius Medical Care Holdings, Inc. and Renal Care Group, Inc., completed the sale of 96 freestanding renal dialysis centers to a wholly-owned subsidiary of DSI Holding Company, Inc ("DSI"), including centers divested pursuant to a consent agreement with the Federal Trade Commission ("FTC").+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
March 24, 2006<\/p>
<\/p>Fresenius Medical Care expands Production Capacity for Dialysers in North America<\/i><\/b><\/a>
<\/p>Fresenius Medical Care AG & Co. KGaA (FWB: FME, FME3) (NYSE: FMS, FMS-p), the world’s largest provider of dialysis products and services, today announced the expansion of its Ogden, Utah production facility. This expansion will increase the production capacity from 27 million to more than 33 million dialyzers annually.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
February 22, 2006<\/p>
<\/p>Fresenius Medical Care reports Fourth Quarter and Full Year 2005 Results<\/i><\/b><\/a>
<\/p>The Company exceeded its financial targets, achieved record earnings and proposes its 9th consecutive annual dividend increase.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
February 13, 2006<\/p>
<\/p>Fresenius Medical Care Successfully completes the convertion of preferences shares and the transformation into KGaA<\/i><\/b><\/a>
<\/p>Fresenius Medical Care AG & Co. KGaA ("the Company") (Frankfurt Stock Exchange: FME, FME3) (NYSE: FMS, FMS-p), the world’s largest provider of Dialysis Products and Services, today announced the completion of the conversion of preference shares into ordinary shares and the transformation of the legal form of the Company from an Aktiengesellschaft into a partnership limited by shares (Kommanditgesellschaft auf Aktien - KGaA).+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>
<\/a>
January 22, 2006<\/p>
<\/p>Fresenius Medical Care wins German Business Innovation Award<\/i><\/b><\/a>
<\/p>Fresenius Medical Care has won the 26th German Business Innovation Award for its newly developed 5008 therapy system for patients with chronic kidney failure. The award was presented during a gala celebration on the evening of January 21 at the Old Opera House in Frankfurt. The prize recognizes the best innovations and outstanding technical-scientific advancements in Germany since 1980. Nearly 220 companies took part in the 2005 competition.+<\/a><\/span><\/div>
<\/p>
<\/p>
<\/p>");